Wednesday, February 9, 2011

FDA Approves Drug to Reduce Risk of Preterm Delivery

FDA Chicago Tribune: FDA approves drug to reduce risk of premature births, by Andrew Zajac & Thomas H. Maugh II:

The drug, a synthetic form of the hormone progesterone, is being marketed under the name Makena. The manufacturer will be required to do further studies to demonstrate the drug's efficacy.

For the first time, the Food and Drug Administration on Friday approved a drug to reduce the risk of premature delivery, although it required the manufacturer to conduct more studies to demonstrate the drug's efficacy.

The agency gave the nod to a synthetic form of the hormone progesterone, which is normally produced during pregnancy, to be injected into women who have already had a spontaneous preterm birth. . . .

https://lawprofessors.typepad.com/reproductive_rights/2011/02/fda-approves-drug-which-reduces-risk-of-premature-births.html

Medical News, Pregnancy & Childbirth, President/Executive Branch, Reproductive Health & Safety | Permalink

TrackBack URL for this entry:

https://www.typepad.com/services/trackback/6a00d8341bfae553ef0147e24d75d8970b

Listed below are links to weblogs that reference FDA Approves Drug to Reduce Risk of Preterm Delivery:

Comments

Post a comment